Efficacy of m-Health for the detection of adverse events following immunization - The stimulated telephone assisted rapid safety surveillance (STARSS) randomised control trial.
CONCLUSION: We have demonstrated that the STARSS methodology improves AEFI detection. Our findings should inform the wider use of SMS-based surveillance which is particularly relevant since establishing robust and novel pharmacovigilance systems is critical to monitoring novel vaccines which includes potential COVID vaccines.
PMID: 33279317 [PubMed - as supplied by publisher]
Source: Vaccine - Category: Allergy & Immunology Authors: Gold MS, Lincoln G, Cashman P, Braunack-Mayer A, Stocks N Tags: Vaccine Source Type: research